4.7 Article

Chronoeffects of the Herbal Medicines Puerariae radix and Coptidis rhizoma in Mice: A Potential Role of REV-ERBα

期刊

FRONTIERS IN PHARMACOLOGY
卷 12, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2021.707844

关键词

chronoefficacy; dosing time; puerariae radix; coptidis rhizoma; hyperhomocysteinemia; chronic colitis

资金

  1. National Natural Science Foundation of China [81722049]
  2. Guangzhou Science and Technology Project [201904010472]

向作者/读者索取更多资源

Identifying drugs with dosing time-dependent effects and understanding the role of REV-ERB alpha as a drug target can improve drug treatment outcomes. The herbal medicines Puerariae radix and Coptidis rhizoma have demonstrated chronoeffects in mice, with PR alleviating hyperhomocysteinemia and CR attenuating chronic colitis in a dosing time-dependent manner, possibly attributed to diurnal expression of REV-ERB alpha.
Identifying drugs with dosing time-dependent effects (chronoeffects) and understanding the underlying mechanisms would help to improve drug treatment outcome. Here, we aimed to determine chronoeffects of the herbal medicines Puerariae radix (PR) and Coptidis rhizoma (CR), and investigate a potential role of REV-ERB alpha as a drug target in generating chronoeffects. The pharmacological effect of PR on hyperhomocysteinemia in mice was evaluated by measuring total homocysteine, triglyceride levels and lipid accumulation. PR dosed at ZT10 generated a stronger effect on hyperhomocysteinemia than drug dosed at ZT2. Furthermore, PR increased the expression levels of REV-ERB alpha target genes Bhmt, Cbs and Cth (encoding three key enzymes responsible for homocysteine catabolism), thereby alleviating hyperhomocysteinemia in mice. Moreover, CR attenuated chronic colitis in mice in a dosing time-dependent manner based on measurements of disease activity index, colon length, malondialdehyde/myeloperoxidase activities and IL-1 beta/IL-6 levels. ZT10 dosing generated a stronger anti-colitis effect as compared to ZT2 dosing. This was accompanied by lower production of colonic inflammatory cytokines (i.e., Nlrp3, IL-1 beta, IL-6, Tnf-alpha and Ccl2, REV-ERB alpha target genes) in colitis mice dosed at ZT10. The diurnal patterns of PR and CR effects were respectively consistent with those of puerarin (a main active constituent of PR, a REV-ERB alpha antagonist) and berberine (a main active constituent of CR, a REV-ERB alpha agonist). In addition, loss of Rev-erb alpha in mice abolished the dosing time-dependency in PR and CR effects. In conclusion, the therapeutic effects of PR and CR depend on dosing time in mice, which are probably attributed to diurnal expression of REV-ERB alpha as the drug target. Our findings have implications for improving therapeutic outcomes of herbal medicines with a chronotherapeutic approach.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据